CCL2 and diffuse large B-cell lymphoma: Consistent with our analysis, it was reported that CREBBP can alter tumor-associated macrophage polarization via the FBXW7-NOTCH-CCL2/CSF1 axis, resulting in tumor progression in diffuse large B-cell lymphoma (37).